Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.39B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1B |
| 3 |
Citigroup
C
|
+$332M |
| 4 |
Apple
AAPL
|
+$307M |
| 5 |
Oracle
ORCL
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$579M |
| 2 |
EA
Electronic Arts
EA
|
+$233M |
| 3 |
Keurig Dr Pepper
KDP
|
+$215M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$206M |
| 5 |
XL
XL Group Ltd.
XL
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.09% |
| 2 | Financials | 12.89% |
| 3 | Healthcare | 12.4% |
| 4 | Consumer Discretionary | 9.65% |
| 5 | Industrials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Amplify Cybersecurity ETF
HACK
$2.82B
| $323K | ﹤0.01% |
+8,041
| New | +$313K |
|
|
ONCT
3427
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $323K | ﹤0.01% |
1,471
+1,323
| +894% | +$3.17M |
|
|
CFRX
3428
DELISTED
ContraFect Corporation
CFRX
| $322K | ﹤0.01% |
194
+112
| +137% | +$185K |
|
3429
Corvus Pharmaceuticals
CRVS
$1.19B
| $321K | ﹤0.01% |
37,370
-308,204
| -89% | -$3.08M |
|
|
CYOU
3430
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $320K | ﹤0.01% |
24,255
-253,863
| -91% | -$3.65M |
|
3431
Arrow Electronics
ARW
$10.3B
| $318K | ﹤0.01% |
4,310
-153,792
| -97% | -$11.8M |
|
3432
Zumiez
ZUMZ
$312M
| $318K | ﹤0.01% |
12,079
-234,209
| -95% | -$6.14M |
|
3433
electroCore
ECOR
$87M
| $317K | ﹤0.01% |
1,510
-1,417
| -48% | -$312K |
|
3434
Westamerica Bancorp
WABC
$1.35B
| $317K | ﹤0.01% |
+5,261
| New | +$323K |
|
|
EOS
3435
Eaton Vance Enhance Equity Income Fund II
EOS
$1.14B
| $316K | ﹤0.01% |
+17,876
| New | +$314K |
|
3436
MediWound
MDWD
$168M
| $316K | ﹤0.01% |
7,331
-3,273
| -31% | -$147K |
|
3437
Amplify Alternative Harvest ETF
MJ
$116M
| $316K | ﹤0.01% |
+658
| New | +$247K |
|
3438
Cenntro
CENN
$9.87M
| – | – |
0
| – | – |
|
|
CSW
3439
CSW Industrials
CSW
$5.34B
| $315K | ﹤0.01% |
5,863
-135,028
| -96% | -$7.37M |
|
3440
Marker Therapeutics
MRKR
$25M
| $315K | ﹤0.01% |
+3,479
| New | +$299K |
|
|
MCBC
3441
DELISTED
Macatawa Bank Corp
MCBC
| $314K | ﹤0.01% |
26,797
-5,073
| -16% | -$62.5K |
|
|
SINA
3442
DELISTED
Sina Corp
SINA
| $314K | ﹤0.01% |
4,525
-124,507
| -96% | -$9.33M |
|
|
THQ
3443
abrdn Healthcare Opportunities Fund
THQ
$811M
| $313K | ﹤0.01% |
+16,677
| New | +$302K |
|
3444
Tompkins Financial
TMP
$1.41B
| $313K | ﹤0.01% |
3,861
-872
| -18% | -$75.4K |
|
|
TUES
3445
DELISTED
Tuesday Morning Corp
TUES
| $313K | ﹤0.01% |
97,940
-246,968
| -72% | -$731K |
|
3446
Superior Group of Companies
SGC
$203M
| $312K | ﹤0.01% |
16,390
-20,206
| -55% | -$395K |
|
3447
Matsons
MATX
$6.66B
| $309K | ﹤0.01% |
7,798
-15,721
| -67% | -$582K |
|
3448
OP Bancorp
OPBK
$229M
| $309K | ﹤0.01% |
26,616
-14,561
| -35% | -$182K |
|
|
NVTR
3449
PUT
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $308K | ﹤0.01% |
+14,000
| New | +$269K |
|
3450
Astrana Health
ASTH
$1.89B
| $307K | ﹤0.01% |
+13,928
| New | +$293K |
|
Similar funds
Israel Englander's Q3 2018 Portfolio in Review
As of Q3 2018, Israel Englander held 4,590 positions worth $81.6B, up 6.4% from $76.7B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Israel Englander's Q3 2018 filing shows 841 new, 1,291 increased, 1,638 reduced and 748 closed positions. Its largest new stake was Fortive: 27,116,929 shares worth $1.44B. The largest sale was Altaba Inc, an estimated $579M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- Israel Englander's largest Q3 2018 buy was Fortive: 27,116,929 shares worth $1.44B.
- Israel Englander added most to Andeavor in Q3 2018, an estimated $1B increase.
- Israel Englander's biggest Q3 2018 reduction was Altaba Inc, cutting an estimated $579M.
- Israel Englander fully exited XL Group Ltd. in Q3 2018, selling an estimated $190M.
- Israel Englander's ten largest holdings make up 10% of its $81.6B portfolio in Q3 2018.
- Israel Englander opened 841 new positions and closed 748 in Q3 2018.
- Israel Englander's portfolio value rose 6.4% quarter-over-quarter to $81.6B.
Based on Millennium Management's 13F filing for Q3 2018, filed 14 Nov 2018.